GlaxoSmithKline PLCGSK:LSE

1,377
35.00 / 2.61%
20.21m
13.99%
0.5232
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 22 2014 17:07 BST.
See more company Information on this page. Log in or Register for free now
In millions of GBP (except for per share items)
Fiscal data as of Dec 31 2013201320122011
OPERATIONS
Net income5,6284,6785,405
Depreciation/depletion732871893
Non-Cash items1,1902,2532,617
Cash taxes paid, supplemental1,2771,6731,463
Cash interest paid, supplemental749779769
Changes in working capital(1,010)(4,001)(3,195)
Total cash from operations7,2224,3756,250
INVESTING
Capital expenditures(1,701)(1,520)(1,328)
Other investing and cash flow items, total2,225(1,111)1,216
Total cash from investing524(2,631)(112)
FINANCING
Financing cash flow items(1,639)(1,000)(893)
Total cash dividends paid(3,680)(3,814)(3,406)
Issuance (retirement) of stock, net(964)(2,116)(1,932)
Issuance (retirement) of debt, net10.003,579(1.00)
Total cash from financing(6,273)(3,351)(6,232)
NET CHANGE IN CASH
Foreign exchange effects(148)(92)(108)
Net change in cash1,325(1,699)(202)
Net cash-begin balance/reserved for future use3,9065,6055,807
Net cash-end balance/reserved for future use5,2313,9065,605
SUPPLEMENTAL INCOME
Depreciation, supplemental732871893
Cash interest paid, supplemental749779769
Cash taxes paid, supplemental1,2771,6731,463
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.